Show simple item record

dc.contributor.authorGill, Michaelen
dc.contributor.authorGallagher, Louiseen
dc.contributor.authorKenny, Elaineen
dc.contributor.authorMc Grath, Janeen
dc.date.accessioned2014-03-13T12:00:58Z
dc.date.available2014-03-13T12:00:58Z
dc.date.issued2011en
dc.date.submitted2011en
dc.identifier.citationAnney RJ, Kenny EM, O'Dushlaine C, Yaspan BL, Parkhomenka E, Buxbaum JD, Sutcliffe J, Gill M, Gallagher L; Autism Genome Project, Gene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders., Eur J Human Genetics, 19, 10, 2011, 1082 - 1089en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.descriptionPMID:21522181en
dc.description.abstractRecent genome-wide association studies (GWAS) have implicated a range of genes from discrete biological pathways in the aetiology of autism. However, despite the strong influence of genetic factors, association studies have yet to identify statistically robust, replicated major effect genes or SNPs. We apply the principle of the SNP ratio test methodology described by O'Dushlaine et al to over 2100 families from the Autism Genome Project (AGP). Using a two-stage design we examine association enrichment in 5955 unique gene-ontology classifications across four groupings based on two phenotypic and two ancestral classifications. Based on estimates from simulation we identify excess of association enrichment across all analyses. We observe enrichment in association for sets of genes involved in diverse biological processes, including pyruvate metabolism, transcription factor activation, cell-signalling and cell-cycle regulation. Both genes and processes that show enrichment have previously been examined in autistic disorders and offer biologically plausibility to these findingsen
dc.description.sponsorshipWe gratefully acknowledge the families participating in the study and the main funders of the AGP: Autism Speaks (USA), the Health Research Board (HRB, Ireland; AUT/2006/1, AUT/2006/2, PD/2006/48), The Medical Research Council (MRC, UK), Genome Canada/Ontario Genomics Institute and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH Grants: HD055751, HD055782, HD055784, MH52708, MH55284, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institutes for Health Research (CIHR), Assistance Publique ? Ho ? pitaux de Paris (France), Autism Speaks UK, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (Grant: Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundac ?a ? o Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Me ? dicale (France), Fundac ?a ? oparaaCie ? ncia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19 October 2001), the John P Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). DP is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). SWS holds the GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children (Canada)en
dc.format.extent1082en
dc.format.extent1089en
dc.language.isoenen
dc.relation.ispartofseriesEur J Human Geneticsen
dc.relation.ispartofseries19en
dc.relation.ispartofseries10en
dc.rightsYen
dc.subjectPsychiatryen
dc.titleGene-ontology enrichment analysis in two independent family-based samples highlights biologically plausible processes for autism spectrum disorders.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/mgillen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/kennyelen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/sandersjen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/lgallaghen
dc.identifier.rssinternalid76097en
dc.identifier.doihttp://dx.doi.org/10.1038/ejhg.2011.75en
dc.rights.ecaccessrightsOpenAccess
dc.subject.TCDThemeGenes & Societyen
dc.subject.TCDThemeNeuroscienceen
dc.identifier.orcid_id0000-0003-0206-5337en
dc.identifier.urihttp://hdl.handle.net/2262/68288


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record